Top Drug Manufacturers - Specialty & Generic Companies by Market Cap
Total Drug Manufacturers - Specialty & Generic Industry Market Cap: $564.61 Billion
Number of Companies: 928
Explore the largest and most valuable companies in the Drug Manufacturers - Specialty & Generic industry ranked by market capitalization. This list features the top public corporations in this sector and their real-time financial data.
Track live market cap rankings, stock prices, and performance data of leading Drug Manufacturers - Specialty & Generic businesses. Stay updated with the latest information on the industry's most influential companies by market value.
Drug Manufacturers - Specialty & Generic Companies Ranked by Market Value
Track real-time market capitalization of largest public companies in the Drug Manufacturers - Specialty & Generic industry. Compare market cap values, analyze stock performance, and discover leading corporations.
Showing 1 to 150 of 928 companies in this category
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Last Traded Price | 24h Change (%) | 7-Day Change (%) | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Zoetis Inc
NYSE:ZTS
|
$69.57 Billion | $ 69.57 Billion | USA | $155.65 | -0.48% | +3.14% | 69.98 Million |
| 2 |
Takeda Pharmaceutical Company Limited
F:TKDA
|
$21.46 Billion | € 20.91 Billion | Germany | €13.20 | +0.76% | +3.12% | 27.52K |
| 3 |
MERCK Kommanditgesellschaft auf Aktien
PINK:MKGAF
|
$16.21 Billion | $ 16.21 Billion | USA | $125.45 | -11.54% | -9.85% | 15.01K |
| 4 |
Merck KGaA
XETRA:MRK
|
$16.17 Billion | € 15.75 Billion | Germany | €121.90 | -0.04% | +3.48% | 10.21 Million |
| 5 |
Sandoz Group AG
SW:SDZ
|
$15.50 Billion | CHF 14.19 Billion | Switzerland | CHF35.78 | -2.45% | +10.57% | 37.29 Million |
| 6 |
Intracellular Th
NASDAQ:ITCI
|
$13.82 Billion | $ 13.82 Billion | USA | $131.87 | -0.04% | +0.13% | 46.25 Million |
| 7 |
Shionogi & Co. Ltd
PINK:SGIOF
|
$13.09 Billion | $ 13.09 Billion | USA | $15.40 | -0.06% | +24.09% | 15.22K |
| 8 |
United Therapeutics Corporation
NASDAQ:UTHR
|
$12.14 Billion | $ 12.14 Billion | USA | $293.85 | -3.05% | +0.13% | 11.12 Million |
| 9 |
Catalent Inc
NYSE:CTLT
|
$11.45 Billion | $ 11.45 Billion | USA | $63.48 | +0.00% | +1.78% | 72.08 Million |
| 10 |
Neurocrine Biosciences Inc
NASDAQ:NBIX
|
$9.96 Billion | $ 9.96 Billion | USA | $106.59 | -1.02% | +3.26% | 40.84 Million |
| 11 |
Cipla Limited
NSE:CIPLA
|
$9.92 Billion | ₹ 859.45 Billion | India | ₹1550.10 | +0.56% | +1.43% | 36.12 Million |
| 12 |
Viatris Inc
NASDAQ:VTRS
|
$9.04 Billion | $ 9.04 Billion | USA | $8.42 | +0.96% | +9.49% | 331.21 Million |
| 13 |
Divi's Laboratories Limited
NSE:DIVISLAB
|
$8.48 Billion | ₹ 734.41 Billion | India | ₹6087.00 | -0.34% | +2.97% | 13.55 Million |
| 14 |
Dr. Reddy's Laboratories Limited
F:RDDA
|
$7.40 Billion | € 7.21 Billion | Germany | €12.10 | +0.00% | +3.42% | 7.53K |
| 15 |
Eisai Co. Ltd
PINK:ESALF
|
$7.39 Billion | $ 7.39 Billion | USA | $26.60 | +1.68% | -11.01% | 103.45K |
| 16 |
Lantheus Holdings Inc
NASDAQ:LNTH
|
$6.55 Billion | $ 6.55 Billion | USA | $105.92 | +1.51% | +4.66% | 19.60 Million |
| 17 |
Lupin Limited
NSE:LUPIN
|
$5.85 Billion | ₹ 506.96 Billion | India | ₹2095.60 | +1.38% | +2.39% | 31.99 Million |
| 18 |
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
$5.74 Billion | Skr 64.41 Billion | Sweden | Skr293.00 | +0.27% | +10.40% | 8.35 Million |
| 19 |
GDERF
OTCGREY:GDERF
|
$5.49 Billion | $ 5.49 Billion | USA | $108.10 | +0.00% | +0.00% | 500.00 |
| 20 |
Yunnan Baiyao Group Co Ltd
SHE:000538
|
$5.40 Billion | CN¥ 39.60 Billion | China | CN¥57.27 | -0.80% | -1.41% | 229.16 Million |
| 21 |
Shanghai Fosun Pharmaceutical Group Co Ltd
SHG:600196
|
$5.34 Billion | CN¥ 39.20 Billion | China | CN¥23.40 | -1.76% | -4.10% | 425.81 Million |
| 22 |
Galderma Group N
SW:GALD
|
$5.32 Billion | CHF 4.87 Billion | Switzerland | CHF95.90 | +1.64% | +23.74% | 11.76 Million |
| 23 |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
$4.78 Billion | € 4.66 Billion | Germany | €26.92 | +0.15% | +5.49% | 12.12K |
| 24 |
Elanco Animal Health
NYSE:ELAN
|
$4.66 Billion | $ 4.66 Billion | USA | $9.48 | -2.67% | +6.64% | 141.57 Million |
| 25 |
Alkermes Plc
NASDAQ:ALKS
|
$4.47 Billion | $ 4.47 Billion | USA | $30.58 | +6.29% | +12.63% | 46.87 Million |
| 26 |
Zhejiang Nhu Co Ltd
SHE:002001
|
$4.30 Billion | CN¥ 31.58 Billion | China | CN¥22.11 | +0.00% | +0.27% | 580.79 Million |
| 27 |
Yuhan Corp Preferred
KO:000105
|
$4.24 Billion | ₩ 6.21 Trillion | Korea | ₩99900.00 | -0.60% | -1.87% | 152.30K |
| 28 |
PharmaEssentia
TW:6446
|
$4.06 Billion | NT$ 134.41 Billion | Taiwan | NT$525.00 | -1.32% | +8.70% | 39.47 Million |
| 29 |
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
|
$4.06 Billion | ₹ 351.44 Billion | India | ₹3322.00 | -0.02% | +2.33% | 9.52 Million |
| 30 |
Siegfried Holding AG
OTCGREY:SGFEF
|
$4.05 Billion | $ 4.05 Billion | USA | $1025.00 | +0.00% | +6.22% | 103.00 |
| 31 |
Prestige Brand Holdings Inc
NYSE:PBH
|
$3.98 Billion | $ 3.98 Billion | USA | $81.23 | -0.85% | +1.25% | 9.40 Million |
| 32 |
Aurobindo Pharma Limited
NSE:AUROPHARMA
|
$3.87 Billion | ₹ 335.47 Billion | India | ₹1229.10 | +1.61% | +3.49% | 39.75 Million |
| 33 |
Huadong Medicine Co Ltd
SHE:000963
|
$3.86 Billion | CN¥ 28.29 Billion | China | CN¥38.85 | +3.85% | -2.85% | 456.44 Million |
| 34 |
Krka d. d
WAR:KRK
|
$3.82 Billion | zł 15.90 Billion | Poland | zł746.00 | +0.54% | -0.27% | 2.81K |
| 35 |
Prestige Consumer Healthcare Inc
F:PBV
|
$3.57 Billion | € 3.48 Billion | Germany | €71.00 | +2.16% | +4.41% | 480.00 |
| 36 |
Changchun High & New Technology Industries Group Inc
SHE:000661
|
$3.50 Billion | CN¥ 25.70 Billion | China | CN¥87.90 | +0.43% | +3.07% | 158.11 Million |
| 37 |
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
$3.16 Billion | CN¥ 23.22 Billion | China | CN¥54.41 | +0.76% | -13.57% | 176.73 Million |
| 38 |
Ipsen S.A
PINK:IPSEF
|
$3.10 Billion | $ 3.10 Billion | USA | $110.53 | +0.00% | -8.31% | 2.52K |
| 39 |
HANSOH PHARMAC. HD-00001
F:3KY
|
$3.08 Billion | € 3.00 Billion | Germany | €2.70 | +3.05% | +0.75% | 9.19K |
| 40 |
Perrigo Company plc
F:PIG
|
$3.06 Billion | € 2.98 Billion | Germany | €22.33 | +1.50% | +6.33% | 5.96K |
| 41 |
Ipsen SA
PA:IPN
|
$3.01 Billion | € 2.93 Billion | France | €102.10 | +2.15% | +10.92% | 2.24 Million |
| 42 |
Hansoh Pharmaceutical Group Company Limited
PINK:HNSPF
|
$2.99 Billion | $ 2.99 Billion | USA | $2.69 | +0.00% | +0.00% | 0.00 |
| 43 |
Mankind Pharma Ltd
NSE:MANKIND
|
$2.93 Billion | ₹ 253.45 Billion | India | ₹2465.30 | -3.58% | -4.43% | 10.83 Million |
| 44 |
Humanwell Healthcare Group Co Ltd
SHG:600079
|
$2.79 Billion | CN¥ 20.47 Billion | China | CN¥20.87 | +0.24% | +0.10% | 474.08 Million |
| 45 |
SHANG.FOS.PHARM.GR.H YC 1
F:08HH
|
$2.68 Billion | € 2.61 Billion | Germany | €1.56 | -3.65% | -2.63% | 19.65K |
| 46 |
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
$2.68 Billion | CN¥ 19.65 Billion | China | CN¥1.96 | +2.08% | -0.51% | 4.01 Billion |
| 47 |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999
|
$2.65 Billion | CN¥ 19.48 Billion | China | CN¥41.12 | -0.60% | -8.36% | 274.29 Million |
| 48 |
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
$2.56 Billion | CN¥ 18.76 Billion | China | CN¥15.21 | +2.22% | -0.46% | 321.50 Million |
| 49 |
Zydus Lifesciences Limited
NSE:ZYDUSLIFE
|
$2.55 Billion | ₹ 221.26 Billion | India | ₹888.25 | +0.02% | +4.17% | 50.09 Million |
| 50 |
Laurus Labs Limited
NSE:LAURUSLABS
|
$2.55 Billion | ₹ 221.01 Billion | India | ₹603.85 | -2.20% | -7.34% | 66.15 Million |
| 51 |
Sichuan Biokin Pharmaceutical Co. Ltd. A
SHG:688506
|
$2.41 Billion | CN¥ 17.67 Billion | China | CN¥286.08 | -1.06% | -1.86% | 32.04 Million |
| 52 |
Glenmark Pharmaceuticals Limited
NSE:GLENMARK
|
$2.27 Billion | ₹ 196.48 Billion | India | ₹1381.20 | -0.23% | -0.69% | 20.18 Million |
| 53 |
IPCA Laboratories Limited
NSE:IPCALAB
|
$2.26 Billion | ₹ 195.33 Billion | India | ₹1401.20 | +0.63% | -2.93% | 6.99 Million |
| 54 |
Livzon Pharmaceutical Group Inc
SHE:000513
|
$2.21 Billion | CN¥ 16.25 Billion | China | CN¥34.58 | -0.12% | -0.63% | 131.94 Million |
| 55 |
Alkem Laboratories Limited
NSE:ALKEM
|
$2.20 Billion | ₹ 190.66 Billion | India | ₹5116.00 | +1.69% | +2.04% | 2.21 Million |
| 56 |
Deciphera Pharmaceuticals Inc
F:D05
|
$2.02 Billion | € 1.97 Billion | Germany | €42.45 | +0.35% | +5.86% | 169.83 Million |
| 57 |
Walvax BioTech
SHE:300142
|
$1.92 Billion | CN¥ 14.07 Billion | China | CN¥10.00 | +1.11% | -2.34% | 581.39 Million |
| 58 |
Hisamitsu Pharmaceutical Co. Inc
F:HPX
|
$1.85 Billion | € 1.80 Billion | Germany | €26.40 | +1.54% | -5.04% | 1.80K |
| 59 |
Abbott India Limited
NSE:ABBOTINDIA
|
$1.80 Billion | ₹ 155.93 Billion | India | ₹29985.00 | -0.38% | -3.32% | 180.75K |
| 60 |
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623
|
$1.79 Billion | CN¥ 13.11 Billion | China | CN¥15.97 | +1.98% | -0.93% | 267.24 Million |
| 61 |
Zhejiang Medicine Co Ltd
SHG:600216
|
$1.73 Billion | CN¥ 12.72 Billion | China | CN¥13.33 | -1.19% | -1.33% | 515.96 Million |
| 62 |
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
|
$1.73 Billion | CN¥ 12.70 Billion | China | CN¥29.52 | +0.00% | -2.64% | 114.31 Million |
| 63 |
Betta Pharmaceuticals Co Ltd
SHE:300558
|
$1.58 Billion | CN¥ 11.61 Billion | China | CN¥50.56 | +1.12% | +1.40% | 205.16 Million |
| 64 |
Tsumura & Co
MU:TSUA
|
$1.58 Billion | € 1.54 Billion | Germany | €23.60 | +0.00% | +0.00% | 0.00 |
| 65 |
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
$1.57 Billion | $ 1.57 Billion | USA | $32.45 | -0.09% | +5.22% | 12.16 Million |
| 66 |
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
$1.57 Billion | CN¥ 11.52 Billion | China | CN¥22.33 | -0.40% | -2.79% | 283.35 Million |
| 67 |
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
$1.55 Billion | $ 1.55 Billion | USA | $8.85 | +4.86% | +13.17% | 80.49 Million |
| 68 |
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SHE:000766
|
$1.54 Billion | CN¥ 11.29 Billion | China | CN¥17.47 | -3.85% | -3.43% | 491.33 Million |
| 69 |
JB Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM
|
$1.49 Billion | ₹ 129.32 Billion | India | ₹1612.40 | +1.70% | -2.63% | 15.28 Million |
| 70 |
Piramal Pharma Limited
NSE:PPLPHARMA
|
$1.48 Billion | ₹ 128.53 Billion | India | ₹211.05 | -0.43% | -5.97% | 154.24 Million |
| 71 |
Bausch Health Companies Inc
TO:BHC
|
$1.41 Billion | CA$ 2.02 Billion | Canada | CA$7.31 | -0.27% | +1.81% | 11.11 Million |
| 72 |
LIVZON PHARMAC. GRP H YC1
F:LP6
|
$1.35 Billion | € 1.31 Billion | Germany | €2.80 | -0.71% | -8.50% | 14.31K |
| 73 |
HUTCHMED (CHINA) LS-1
F:H7T2
|
$1.33 Billion | € 1.30 Billion | Germany | €2.50 | -0.79% | -7.41% | 12.40K |
| 74 |
H Lundbeck A/S
CO:HLUN-B
|
$1.32 Billion | Dkr 9.57 Billion | Denmark | Dkr31.34 | +3.36% | +13.80% | 13.40 Million |
| 75 |
Henan Lingrui Pharmaceutical Co Ltd
SHG:600285
|
$1.32 Billion | CN¥ 9.65 Billion | China | CN¥22.85 | -1.93% | +0.57% | 174.52 Million |
| 76 |
Cansino Biologics Inc
SHG:688185
|
$1.31 Billion | CN¥ 9.64 Billion | China | CN¥56.85 | +4.33% | +2.62% | 35.76 Million |
| 77 |
Ajanta Pharma Limited
NSE:AJANTPHARM
|
$1.31 Billion | ₹ 113.51 Billion | India | ₹2706.10 | -2.16% | +0.89% | 2.36 Million |
| 78 |
Joincare Pharmaceutical Group Industry Co Ltd
SHG:600380
|
$1.30 Billion | CN¥ 9.54 Billion | China | CN¥10.60 | -0.93% | +0.00% | 482.63 Million |
| 79 |
Fagron NV
BR:FAGR
|
$1.28 Billion | € 1.25 Billion | Belgium | €20.50 | +0.99% | +8.58% | 1.49 Million |
| 80 |
BORA PHARMACEUTICALS LTD
TW:6472
|
$1.27 Billion | NT$ 41.98 Billion | Taiwan | NT$712.00 | -0.42% | +8.70% | 26.99 Million |
| 81 |
Suven Pharmaceuticals Limited
NSE:SUVENPHAR
|
$1.26 Billion | ₹ 108.77 Billion | India | ₹1137.10 | +0.06% | -7.55% | 7.67 Million |
| 82 |
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
$1.25 Billion | CN¥ 9.15 Billion | China | CN¥13.74 | +1.63% | +1.03% | 322.87 Million |
| 83 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NYSE:AMRX
|
$1.23 Billion | $ 1.23 Billion | USA | $7.74 | +1.04% | +6.03% | 47.37 Million |
| 84 |
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
$1.21 Billion | CN¥ 8.90 Billion | China | CN¥26.29 | -0.60% | +0.57% | 157.95 Million |
| 85 |
Hybio Pharmaceutical
SHE:300199
|
$1.20 Billion | CN¥ 8.84 Billion | China | CN¥13.79 | -0.93% | -2.75% | 1.66 Billion |
| 86 |
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
$1.19 Billion | $ 1.19 Billion | USA | $70.82 | +0.08% | +2.71% | 9.61 Million |
| 87 |
Gland Pharma Limited
NSE:GLAND
|
$1.18 Billion | ₹ 102.48 Billion | India | ₹1400.00 | -0.91% | -3.51% | 9.77 Million |
| 88 |
Dynavax Technologies Corporation
NASDAQ:DVAX
|
$1.17 Billion | $ 1.17 Billion | USA | $11.75 | +1.73% | +9.61% | 64.68 Million |
| 89 |
Pacira BioSciences, Inc.
NASDAQ:PCRX
|
$1.16 Billion | $ 1.16 Billion | USA | $26.75 | -0.56% | +6.15% | 22.78 Million |
| 90 |
Hanmi Pharm Co Ltd
KO:128940
|
$1.14 Billion | ₩ 1.67 Trillion | Korea | ₩269000.00 | +8.91% | +12.32% | 1.15 Million |
| 91 |
Faes Farma SA
MC:FAE
|
$1.12 Billion | € 1.10 Billion | Spain | €4.27 | +1.55% | +6.35% | 15.90 Million |
| 92 |
Hypera S.A
SA:HYPE3
|
$1.12 Billion | R$ 6.85 Billion | Brazil | R$24.12 | +3.43% | +17.32% | 79.97 Million |
| 93 |
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
$1.11 Billion | CN¥ 8.16 Billion | China | CN¥7.23 | -3.73% | -2.17% | 368.01 Million |
| 94 |
Jiangzhong Pharmaceutical Co Ltd
SHG:600750
|
$1.11 Billion | CN¥ 8.16 Billion | China | CN¥22.91 | +0.09% | -1.25% | 180.86 Million |
| 95 |
Wockhardt Limited
NSE:WOCKPHARMA
|
$1.11 Billion | ₹ 96.26 Billion | India | ₹1296.70 | -4.91% | -8.11% | 13.22 Million |
| 96 |
Shenzhen Kangtai Biological Products Co Ltd
SHE:300601
|
$1.10 Billion | CN¥ 8.08 Billion | China | CN¥13.61 | +0.52% | -2.23% | 302.48 Million |
| 97 |
Natco Pharma Limited
NSE:NATCOPHARM
|
$1.10 Billion | ₹ 95.13 Billion | India | ₹850.90 | -3.67% | +1.38% | 34.14 Million |
| 98 |
Yantai Dongcheng Pharmaceutical Co Ltd
SHE:002675
|
$1.09 Billion | CN¥ 8.03 Billion | China | CN¥14.95 | -0.20% | -3.24% | 342.83 Million |
| 99 |
Lotus Pharmaceutical Co Ltd
TW:1795
|
$1.09 Billion | NT$ 35.93 Billion | Taiwan | NT$219.50 | +0.00% | +6.30% | 45.28 Million |
| 100 |
Indivior PLC Ordinary Shares
NASDAQ:INDV
|
$1.06 Billion | $ 1.06 Billion | USA | $11.51 | -2.04% | +30.65% | 25.35 Million |
| 101 |
Genomma Lab Internacional S.A.B. de C.V
MX:LABB
|
$1.06 Billion | MX$ 21.78 Billion | Mexico | MX$22.92 | -6.87% | +3.15% | 72.56 Million |
| 102 |
Hypera SA
PINK:HYPMY
|
$1.05 Billion | $ 1.05 Billion | USA | $3.59 | +0.00% | +2.28% | 609.09K |
| 103 |
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
$1.02 Billion | CN¥ 7.46 Billion | China | CN¥18.86 | +0.27% | +3.00% | 322.08 Million |
| 104 |
China Resources Pharmaceutical Group Limited
F:640
|
$1.01 Billion | € 982.45 Million | Germany | €0.54 | +0.00% | -0.92% | 72.00K |
| 105 |
Apeloa Pharmaceutical Co Ltd
SHE:000739
|
$999.33 Million | CN¥ 7.33 Billion | China | CN¥13.72 | +0.66% | +0.22% | 239.57 Million |
| 106 |
Neuland Laboratories Limited
NSE:NEULANDLAB
|
$993.59 Million | ₹ 86.05 Billion | India | ₹11992.00 | -2.33% | -8.26% | 1.29 Million |
| 107 |
Laboratorios Farmaceuticos ROVI
MC:ROVI
|
$991.95 Million | € 966.37 Million | Spain | €51.55 | +0.29% | +3.93% | 2.98 Million |
| 108 |
INDIVIOR PLC DL 050
F:2IVB
|
$974.86 Million | € 949.72 Million | Germany | €10.30 | +0.00% | +29.56% | 6.64K |
| 109 |
Evotec SE
XETRA:EVT
|
$971.81 Million | € 946.74 Million | Germany | €7.33 | -2.42% | +7.26% | 24.72 Million |
| 110 |
Dizal (Jiangsu) Pharmaceutical Co. Ltd. A
SHG:688192
|
$967.94 Million | CN¥ 7.10 Billion | China | CN¥57.91 | +0.38% | -1.43% | 116.52 Million |
| 111 |
KPC Pharmaceuticals Inc
SHG:600422
|
$963.60 Million | CN¥ 7.07 Billion | China | CN¥15.30 | -0.39% | -15.19% | 367.92 Million |
| 112 |
Zhejiang Jingxin Pharmaceutical Co Ltd
SHE:002020
|
$955.75 Million | CN¥ 7.01 Billion | China | CN¥13.65 | +0.00% | -3.60% | 366.61 Million |
| 113 |
Green Thumb Industries Inc
OTCQX:GTBIF
|
$943.61 Million | $ 943.61 Million | USA | $5.02 | -5.82% | -9.06% | 14.39 Million |
| 114 |
Mayinglong Pharmaceutical Group Co Ltd
SHG:600993
|
$941.27 Million | CN¥ 6.91 Billion | China | CN¥25.62 | -0.74% | -4.30% | 199.72 Million |
| 115 |
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
$936.19 Million | CN¥ 6.87 Billion | China | CN¥13.70 | -1.58% | -0.87% | 586.86 Million |
| 116 |
Shandong Lukang Pharmaceutical Co Ltd
SHG:600789
|
$930.60 Million | CN¥ 6.83 Billion | China | CN¥9.91 | -1.39% | -3.60% | 3.33 Billion |
| 117 |
Zhejiang CONBA Pharmaceutical Co Ltd
SHG:600572
|
$908.87 Million | CN¥ 6.67 Billion | China | CN¥4.39 | -1.35% | -1.35% | 637.19 Million |
| 118 |
Amphastar P
NASDAQ:AMPH
|
$895.94 Million | $ 895.94 Million | USA | $24.41 | -0.37% | +2.01% | 14.81 Million |
| 119 |
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
|
$869.14 Million | CN¥ 6.38 Billion | China | CN¥39.83 | +1.66% | +2.65% | 408.75 Million |
| 120 |
Kaken Pharmaceutical Co. Ltd
PINK:KKPCF
|
$865.32 Million | $ 865.32 Million | USA | $26.31 | +0.00% | +0.00% | 0.00 |
| 121 |
Kissei Pharmaceutical Co. Ltd
PINK:KSPHF
|
$861.19 Million | $ 861.19 Million | USA | $23.85 | +0.00% | +0.00% | 0.00 |
| 122 |
Sumitomo Pharma Co. Ltd
PINK:SMDPY
|
$860.70 Million | $ 860.70 Million | USA | $4.78 | +0.00% | +0.00% | 0.00 |
| 123 |
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
|
$846.69 Million | CN¥ 6.21 Billion | China | CN¥3.38 | +0.90% | +0.90% | 1.02 Billion |
| 124 |
Chongqing Taiji Industry Group Co Ltd
SHG:600129
|
$797.18 Million | CN¥ 5.85 Billion | China | CN¥20.59 | +0.05% | +0.15% | 370.83 Million |
| 125 |
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
$787.42 Million | CN¥ 5.78 Billion | China | CN¥11.13 | -0.98% | -6.00% | 575.45 Million |
| 126 |
Almirall S.A.
MC:ALM
|
$769.43 Million | € 749.59 Million | Spain | €9.75 | -0.10% | +4.84% | 2.90 Million |
| 127 |
GRAND PHARM. GRP. HD-01
F:MX6A
|
$769.28 Million | € 749.44 Million | Germany | €0.66 | +0.77% | +1.55% | 13.90K |
| 128 |
Shanghai Shyndec Pharmaceutical Co Ltd
SHG:600420
|
$756.27 Million | CN¥ 5.55 Billion | China | CN¥10.23 | -0.87% | -0.49% | 418.12 Million |
| 129 |
Guangxi Wuzhou Zhongheng Group Co Ltd
SHG:600252
|
$751.08 Million | CN¥ 5.51 Billion | China | CN¥2.43 | +0.83% | +1.25% | 981.93 Million |
| 130 |
Granules India Limited
NSE:GRANULES
|
$747.00 Million | ₹ 64.69 Billion | India | ₹455.80 | +0.04% | -5.05% | 28.53 Million |
| 131 |
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
$738.53 Million | $ 738.53 Million | USA | $27.06 | +0.24% | +4.12% | 8.91 Million |
| 132 |
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
$730.22 Million | $ 730.22 Million | USA | $8.61 | -3.15% | +3.61% | 25.62 Million |
| 133 |
Zhejiang Garden Bio-chemical High-tech Co Ltd
SHE:300401
|
$722.18 Million | CN¥ 5.30 Billion | China | CN¥15.15 | +1.27% | +3.55% | 610.17 Million |
| 134 |
BIOGAIA AB B O.N.
F:BGLA
|
$720.05 Million | € 701.48 Million | Germany | €9.03 | -1.04% | -1.04% | 4.01K |
| 135 |
BioGaia AB (publ)
ST:BIOG-B
|
$710.18 Million | Skr 7.97 Billion | Sweden | Skr102.50 | +3.07% | +1.89% | 3.64 Million |
| 136 |
Renhe Pharmacy Co Ltd
SHE:000650
|
$706.51 Million | CN¥ 5.18 Billion | China | CN¥5.38 | +0.00% | +0.00% | 379.86 Million |
| 137 |
Shandong Shanda Wit Science and Technology Co Ltd
SHE:000915
|
$702.38 Million | CN¥ 5.15 Billion | China | CN¥30.54 | +0.16% | -3.14% | 176.81 Million |
| 138 |
Alvotech
IC:ALVO
|
$698.03 Million | Ikr 98.24 Billion | Iceland | Ikr990.00 | -1.49% | -9.17% | 6.86 Million |
| 139 |
SIMCERE PHARMAC. GRP LTD
F:S2P
|
$690.12 Million | € 672.32 Million | Germany | €0.98 | +0.00% | +2.62% | 2.66K |
| 140 |
Harbin Gloria Pharmaceuticals
SHE:002437
|
$674.33 Million | CN¥ 4.95 Billion | China | CN¥2.46 | -0.81% | -0.81% | 2.05 Billion |
| 141 |
Harrow Health Inc
NASDAQ:HROW
|
$674.24 Million | $ 674.24 Million | USA | $25.00 | +0.93% | +4.91% | 12.45 Million |
| 142 |
Eris Lifesciences Limited
NSE:ERIS
|
$672.91 Million | ₹ 58.28 Billion | India | ₹1432.10 | -2.23% | +2.34% | 3.79 Million |
| 143 |
Tianjin Ringpu Bio Tech
SHE:300119
|
$671.98 Million | CN¥ 4.93 Billion | China | CN¥20.39 | -2.02% | +17.32% | 318.16 Million |
| 144 |
Dermapharm Holding SE
XETRA:DMP
|
$671.75 Million | € 654.43 Million | Germany | €38.50 | +0.13% | +5.19% | 722.68K |
| 145 |
Jubilant Pharmova Limited
NSE:JUBLPHARMA
|
$669.08 Million | ₹ 57.94 Billion | India | ₹897.95 | +0.36% | -2.10% | 8.66 Million |
| 146 |
Evolus Inc
NASDAQ:EOLS
|
$660.03 Million | $ 660.03 Million | USA | $11.80 | +3.51% | +5.08% | 23.71 Million |
| 147 |
Hanall Biopharma
KO:009420
|
$653.15 Million | ₩ 956.34 Billion | Korea | ₩27750.00 | -1.07% | +0.18% | 5.27 Million |
| 148 |
Guangdong Taienkang Pharmaceutical Co. Ltd
SHE:301263
|
$648.60 Million | CN¥ 4.76 Billion | China | CN¥20.66 | +1.62% | +2.73% | 130.43 Million |
| 149 |
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
$645.01 Million | $ 645.01 Million | USA | $27.74 | +2.86% | +32.85% | 18.62 Million |
| 150 |
Porton Fine Chemicals Ltd
SHE:300363
|
$639.90 Million | CN¥ 4.70 Billion | China | CN¥15.02 | +0.74% | +8.53% | 468.80 Million |
Page 1 of 7